An overview of kinin mediated events in cancer progression and therapeutic applications
K Deepak, PK Roy, P Kola, B Mukherjee… - Biochimica et Biophysica …, 2022 - Elsevier
Kinins are bioactive peptides generated in the inflammatory milieu of the tissue
microenvironment, which is involved in cancer progression and inflammatory response …
microenvironment, which is involved in cancer progression and inflammatory response …
Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression
Ż Kałuzińska-Kołat, D Kołat, K Kośla… - Frontiers in …, 2023 - frontiersin.org
Introduction Glioblastoma (GBM) is notorious for its clinical and molecular heterogeneity,
contributing to therapeutic failure and a grim prognosis. WWOX is one of the tumor …
contributing to therapeutic failure and a grim prognosis. WWOX is one of the tumor …
[HTML][HTML] Assessment of Radiolabelled Derivatives of R954 for Detection of Bradykinin B1 Receptor in Cancer Cells: Studies on Glioblastoma Xenografts in Mice
M Shukuri, S Onoe, T Karube, R Mokudai, H Wakui… - Pharmaceuticals, 2024 - mdpi.com
Bradykinin B1 receptor (B1R) has garnered attention as a cancer therapeutic and diagnostic
target. Several reports on radiolabelled derivatives of B1R antagonists have shown …
target. Several reports on radiolabelled derivatives of B1R antagonists have shown …